After-hours movers: AMC Entertainment, StoneCo, Fulcrum Therapeutics, and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Morgan Stanley Reiterates Equalweight Rating on StoneCo Ltd. (STNE)
May 14, 2024 12:08 PM EDTMorgan Stanley analyst Jorge Kuri reiterated an Equalweight rating and $16.50 price target on StoneCo Ltd. (NASDAQ: STNE)
The analyst comments "While we remain constructive on many of the primary drivers for merchant acquirers accelerating TPV growth in 2024, lower funding costs as rates... More
Citi Reiterates Buy Rating on StoneCo Ltd. (STNE)
May 14, 2024 9:56 AM EDTCiti analyst Gabriel Gusan reiterated a Buy rating and $20.00 price target on StoneCo Ltd. (NASDAQ: STNE)
The analyst comments "We look at Stone's FIDC portfolio evolution in CVM as a proxy for credit operations. The Credit portfolio reached R$592mn in... More
BofA Securities Reiterates Underperform Rating on Fulcrum Therapeutics (FULC)
May 14, 2024 8:47 AM EDTBofA Securities analyst Tazeen Ahmad reiterated an Underperform rating and $5.00 price target on Fulcrum Therapeutics (NASDAQ: FULC).
The analyst comments "FULC announced the company has entered an exclusive license agreement with Sanofi (ticker: SNY; covered by Graham Perry) for the ex-US development of losmapimod in... More
AMC Entertainment (AMC) PT Raised to $3.20 at Citi
May 14, 2024 6:37 AM EDTCiti analyst Jason Bazinet raised the price target on AMC Entertainment (NYSE: AMC) to $3.20 (from $3.10) while maintaining a Sell rating.
The analyst comments "Maintaining Our View Following our update, our target price goes from $3.10 to $3.20. To arrive at our target... More
